surmount-1 tirzepatide trial obesity without diabetes once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 In the SURMOUNT-1 trial (published

Our board-certified obesity medicine providers will provide personalized weight management guidance and prescribe weight loss medications as part of your tailored weight loss strategy

Therefore, these drugs may be particularly beneficial for these patients, she added

Shortages of tirzepatide, sold as a diabetes drug (Mounjaro) and a weight-loss medication (Zepbound), have fueled demand for compounding pharmacies to make their own versions of the medicine, which patients say are cheaper and easier to get

Yes, under medical supervision

They list side effects for each drug separately, as if you are reading two different pamphlets stapled together